论文部分内容阅读
目的探讨莫沙必利、奥美拉唑联合黛力新治疗功能性消化不良(FD)的疗效。方法 67例经确诊的FD患者随机分为2组:观察组35例予以莫沙必利、奥美拉唑联合黛力新治疗,对照组32例予以莫沙必利、奥美拉唑治疗,疗程均4周,观察症状消失及缓解情况并做对比分析。结果治疗2周后观察组和对照组临床症状缓解率分别为77.1%和43.7%,治疗4周后观察组和对照组临床症状缓解率分别为88.6%和53.1%。结论莫沙必利、奥美拉唑治疗FD时加用黛力新疗效将明显提高,起效快,且不良反应轻微。
Objective To investigate the efficacy of mosapride and omeprazole in combination with deacetylene in the treatment of functional dyspepsia (FD). Methods Sixty-seven FD patients diagnosed were randomly divided into two groups: the observation group 35 cases of mosapride, omeprazole combined with Deanxit treatment, the control group 32 cases of mosapride, omeprazole treatment, The course of treatment was 4 weeks, observed symptoms disappeared and mitigation and do comparative analysis. Results After 2 weeks of treatment, the rates of clinical symptoms relief in the observation group and the control group were 77.1% and 43.7%, respectively. After 4 weeks of treatment, the clinical symptoms of the observation group and the control group were 88.6% and 53.1%, respectively. Conclusion Mosapride, omeprazole treatment of FD plus Deanxit new treatment will be significantly improved, rapid onset, and mild adverse reactions.